The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors (Q35597799)
Jump to navigation
Jump to search
scientific article published on 6 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors |
scientific article published on 6 May 2015 |
Statements
1 reference
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors (English)
1 reference
Pinar Iyidogan
1 reference
Casey G Langdon
1 reference
Matthew A Held
1 reference
James T Platt
1 reference
Katrina Meeth
1 reference
Ramanaiah Mamillapalli
1 reference
Andrew B Koo
1 reference
Michael Klein
1 reference
Zongzhi Liu
1 reference
Marcus W Bosenberg
1 reference
David F Stern
1 reference
6 May 2015
1 reference
1 reference
28
1 reference
4
1 reference
417-430
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference